Southern New England Partnership for Stroke Innovation and Treatment (SPIRIT)
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)
This partnership links hospitals and stroke specialists to enroll adults who have had a stroke into clinical trials of new treatments and ways to improve care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11238937 on NIH RePORTER |
What this research studies
This partnership brings together major hospitals and stroke experts in Southern New England and nearby New York to run clinical trials for people who have had a stroke. The coordinating center helps hospitals enroll patients quickly, manages data and follow-up, and supports staff training and trial logistics so studies run smoothly. With a combined catchment of about 8.7 million people and thousands of stroke cases per year, the network can offer more trial options to eligible patients. If you're treated at a participating hospital, you might be invited to join a trial testing new treatments or ways to improve stroke care.
Who could benefit from this research
Good fit: Adults who recently experienced an acute stroke and receive care at one of the participating hospitals are ideal candidates for enrollment.
Not a fit: People without stroke, those treated at nonparticipating hospitals, or patients who do not meet specific trial eligibility may not benefit directly from this network.
Why it matters
Potential benefit: If successful, the network could give stroke patients faster access to new treatments and better organized care that may improve recovery.
How similar studies have performed: Network-based stroke trial efforts like StrokeNet have previously enrolled large numbers of patients and achieved successful trial execution, and this renewal builds on that track record.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Sheth, Kevin Navin — Yale University
- Study coordinator: Sheth, Kevin Navin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.